Our PR and IR tools are designed to meet all necessary regulatory requirements, giving you the confidence to communicate effectively and compliantly. Streamline your communications needs today with our one-stop shop offering.
Private CompaniesWhether a startup or established brand, we deliver the support, targeted distribution, media outreach, and flexible pricing & payment options needed to amplify your story with confidence.
AgenciesWe simplify the process of delivering success for both you and your clients. We understand the importance of getting it right, equipping you with seamless billing, flexible plans and payment structures, and clear reporting and analytics to ensure every campaign runs smoothly and achieves measurable results.
We understand the need to manage high volume of press release distribution efficiently. That's why we offer a dedicated API designed specifically for our legal customers, delivering a streamlined, simple process that ensures value and ease at every step.
Resellers, Publishers & Market ResearchWe understand the importance of cost efficiency for high-volume partners, which is why we offer bulk discounts tailored to meet your needs while maximizing value.
VANCOUVER, BC / ACCESSWIRE / March 29, 2016 / True Leaf Medicine International (CSE: MJ) (FSE: TLA) has reached a significant milestone as a pioneering producer of hemp-based pet nutrition products by signing an agreement with Pet Food Experts, Inc., gaining distribution in the United States for the first time. To view an enhanced version of TRUE HEMP™ Pet Chews, please...
Read more
VANCOUVER, BC / ACCESSWIRE / March 3, 2016 / A success wherever they're sold in Canada, True Leaf International Ltd.'s (CSE: MJ) (FSE: TLA) hemp-based chews for dogs will soon be available for sale in the United States - and the company is celebrating the occasion with a new name and new packaging for the US market. To view an enhanced version of TRUE HEMP™ Pet Chews, please visit:...
Read more
TORONTO, ON / ACCESSWIRE / February 22, 2016 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2.F), a developer of in vitro diagnostics and point-of-care testing (POCT) announces that, in accordance with CSE policies, it intends to extend the expiry date of an aggregate of 8,572,500 previously issued warrants (the "Warrants"). The Warrants were originally issued between July 7, 2014 and September 22, 2014, with original expiry dates ranging...
Read more
VANCOUVER, BC / ACCESSWIRE / February 22, 2016 / True Leaf Medicine International Ltd. (CSE: MJ) (FRANKFURT: TLA) ("True Leaf" or the "Corporation") has signed a consulting services agreement (the "Agreement") with the consulting firm Pet Industry Experts LLC (PIE), headed by the founder of pet industry giant PetSmart ®. The purpose of this relationship is to bring additional expertise to True Leaf as it prepares to launch it hemp-based pet...
Read moreLOS ANGELES, CA / ACCESSWIRE / February 8, 2016 / Gerald Thermos Invents 100% Polyurea Spray Coating Gerald Thermos a leader in the field of polyurea and polyurethane coatings, invents a 100% Polyurea Spray Coating. Gerald has over 25 years of experience in this field, and has even filed for a patent for the processing and use of a 100% polyurea elastomeric system. This invention has the potential to greatly improve the quality of polyureas...
Read more
VANCOUVER, BC / ACCESSWIRE / February 2, 2016 / True Leaf Medicine International Ltd. (CSE: MJ) ("the company") has extended its retail channels for its innovative hemp-based dog chews, effectively covering all 10 Canadian provinces and the three territories. The company has increased the number of stores in British Columbia, Alberta and Ontario, a 35% increase in its retail distribution network. At the same time, True Leaf has added e-commerce...
Read more
VANCOUVER, BC / ACCESSWIRE / January 19, 2016 / True Leaf Medicine International Ltd. (CSE: MJ) (the "Company"), is pleased to announce that it has closed a private placement of 2,005,953 units at a price of $0.105 per unit, yielding gross proceeds of $210,625 to be used to facilitate a move to a larger-scale manufacturing facility in Ontario, Canada and also for general working capital. Each unit is comprised of 1 common share and one-half of...
Read more
VANCOUVER, BC / ACCESSWIRE / January 4, 2016 / True Leaf Medicine International Ltd. (FSE: TLA.F) (CSE: MJ) has arranged a non-brokered private placement of up to 2.142.857 units at a subscription price of $0.10.5 per unit to eligible subscribers for gross proceeds of up to $225,000. Each unit will consist of one common share and one half-share purchase warrant. A whole warrant can be redeemed for one additional common share of the company at $...
Read more
TORONTO, ON / ACCESSWIRE / December 11, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company"), a developer of in vitro diagnostics and point-of-care testing (POCT) devices is pleased to report the development of a proof-of-concept prototype of the Company's HemoPalm(TM) analyzer and associated cartridge for measuring CO-oximetry and bilirubin*. The prototype analyzer uses the same light source and spectrophotometer that...
Read more
VANCOUVER, BC / ACCESSWIRE / December 9, 2015 / Canada's first and so far only hemp-based dog chews are already selling out in stores across Ontario and the West. Now, True Leaf Medicine International Inc. (FSE: TLA) (CSE: MJ) ("True Leaf" or "the Company") is moving to a manufacturer with greater capacity, in order to meet demand. Launched at the end of September, the first product run of the line of treats is on shelves in 35 stores in western...
Read more
TORONTO, ON / ACCESSWIRE / December 8, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company"), a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to report that it has engaged Hochuen International Corp. to produce an enhanced version of its prototype HemoPalm cartridges. ChroMedX Corp. has entered into a development agreement with Hochuen International Corp. to produce the enhanced version of...
Read more
SANTA ANA, CA / ACCESSWIRE / November 24, 2015 / QuantumSphere, Inc. (OTCQB: QSIM), a leading producer of advanced catalyst technologies for industrial chemical processes, announced today that it will be presenting at the 8th annual LD Micro Main Event. Kevin Maloney, Chief Executive Officer, will present QuantumSphere's business model and growth strategy at 11:00 a.m. on Wednesday, December 2, 2015 in Track 4. LD Micro Main Event takes place...
Read more
SUGAR LAND, TX / ACCESSWIRE / November 24, 2015 / Trecora Resources (NYSE: TREC), a leading provider of high purity specialty hydrocarbons and waxes, is scheduled to present at the 8th Annual LD Micro Conference in Los Angeles on Wednesday, December 2, 2015, at the Luxe Sunset Hotel. Trecora's Chief Executive Officer, Simon Upfill-Brown, will present at noon Pacific Time and is available for one-on-one meetings that day. About LD Micro LD Micro...
Read more
VANCOUVER, BC / ACCESSWIRE / November 2, 2015 / True Leaf Medicine International Ltd. (CSE: MJ) (FSE: TLA) has entered into a loan agreement with First Pacific Enterprises Inc. (the "Lender") whereby the Lender has agreed to lend True Leaf CAD $60,000 (the "Loan"). First Pacific Enterprises Inc. is owned by Darcy Bomford, True Leaf's CEO. The Loan will become due and repayable by the Borrower to the Lender on April 30, 2016 (the "Due Date"). The...
Read more
VANCOUVER, BC / ACCESSWIRE / November 2, 2015 / True Leaf Medicine International Ltd. (CNSX: MJ) has entered into negotiations with a European co-packer manufacturer of pet products, secured a European supply of hemp and is reviewing prospective firms to represent the company in Europe. Mr. Narcisse Kayser, former international sales manager for ANF pet foods, has been hired by the company to help manage the initial European strategy. With three...
Read more
TORONTO, ON / ACCESSWIRE / October 16, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company"), a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to announce that it has completed the first tranche of its previously announced non-brokered private placement (the "Offering"), pursuant to which the Company issued and sold an aggregate of 1,750,000 units (each, a "Unit") of the Company at a price of...
Read more
TORONTO, ON / ACCESSWIRE / October 14, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company"), a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to announce that the Company has been awarded a United States patent on its Ultra Filtration technology. ChroMedX was awarded US Pat. No. 9,162,186, entitled "Sample Filtration Assembly". This patent is related to manual ultrafiltration cartridges, and...
Read more
WARSAW, POLAND and ARLINGTON, VA / ACCESSWIRE / October 14, 2015 / The International Centre for Chemical Safety and Security (ICCSS) and The Chlorine Institute (CI) signed a Memorandum of Understanding (MoU) to jointly upgrade practices and policies, develop and conduct training programs and voluntary initiatives, and share expertise and best practices to enhance chlor-alkali chemical safety, security and stewardship worldwide. ICCSS Board...
Read more
TORONTO, ON / ACCESSWIRE / October 9, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company"), a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to announce that it intends to complete a non-brokered private placement (the "Offering") for gross proceeds of up to CDN$800,000 through the issuance of up to 4,000,000 units (each a "Unit") at a price of CDN$0.20 per Unit. Each Unit will be comprised...
Read more
TORONTO, ON / ACCESSWIRE / September 30, 2015 / ChroMedX Corp. (CSE: CHX) (OTCQB: MNLIF) (FSE: EIY2) (the "Company"), a developer of in vitro diagnostics and point-of-care testing (POCT) is pleased to announce that the Company has been awarded two additional Canadian patents on its Automated Ultra Filtration (AUF) technology. These patents demonstrate the novelty, inventiveness and usefulness of the AUF technology, and are listed below: 1. CA...
Read more
